Abstract
Background Patients with congenital adrenal hyperplasia (CAH) are at risk of long-term cognitive and metabolic sequelae with some of the effects being attributed to the chronic glucocorticoid treatment that they receive. This study investigates genome-wide DNA methylation in patients with CAH to determine whether there is evidence for epigenomic reprogramming as well as any relationship to patient outcome.
Methods We analysed CD4+ T cell DNA from 28 patients with CAH (mean age=18.5 ±6.5 years [y]) and 37 population controls (mean age=17.0 ±6.1 y) with the Infinium-HumanMethylation450 BeadChip array to measure genome-wide locus-specific DNA methylation levels. Effects of CAH, phenotype and CYP21A2 genotype on methylation were investigated as well as the association between differentially methylated CpGs, glucose homeostasis, blood lipid profile and cognitive functions. In addition, we report data on a small cohort of 11 patients (mean age=19.1, ±6.0 y) with CAH who were treated prenatally with dexamethasone (DEX) in addition to postnatal glucocorticoid treatment.
Results We identified two CpGs to be associated with patient phenotype: cg18486102 (located in the FAIM2 gene; rho=0.58, adjusted p=0.027) and cg02404636 (located in the SFI1 gene; rho=0.58, adjusted p=0.038). cg02404636 was also associated with genotype (rho=0.59, adjusted p=0.024). Higher levels of serum C-peptide was also observed in patients with CAH (p=0.044). Additionally, levels of C-peptide and HbA1c were positively correlated with patient phenotype (p=0.044 and p=0.034) and genotype (p=0.044 and p=0.033), respectively. No significant association was found between FAIM2 methylation and cognitive or metabolic outcome. However, SFI1 TSS methylation was associated with fasting plasma HDL cholesterol levels (p=0.035).
Conclusion In conclusion, higher methylation levels in CpG sites covering FAIM2 and SFI1 were associated with disease severity. Hypermethylation in these genes may have implications for long-term cognitive and metabolic outcome in patients with CAH.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Marianne and Marcus Wallenberg Foundation, International Fund Congenital Adrenal Hyperplasia (IFCAH)/European Society for Pediatric Endocrinology (ESPE), Stockholm County Council (ALF-SLL), Stiftelsen Frimurare Barnhuset i Stockholm (SFBS), Svenska Läkaresällskapet, Stiftelsen Samariten, Jerringfonden, Sällskapet Barnavård and Wera Ekströms Stiftelse för pediatrisk forskning.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Funding: This work was supported by Marianne and Marcus Wallenberg Foundation, International Fund Congenital Adrenal Hyperplasia (IFCAH)/European Society for Pediatric Endocrinology (ESPE), Stockholm County Council (ALF-SLL), Stiftelsen Frimurare Barnhuset i Stockholm (SFBS), Svenska Läkaresällskapet, Stiftelsen Samariten, Jerringfonden, Sällskapet Barnavård and Wera Ekströms Stiftelse för pediatrisk forskning.
Disclosure statement: The authors have nothing to disclose.
Abbreviations
- CAH
- congenital adrenal hyperplasia
- SW CAH
- salt-wasting
- SV CAH
- simple virilizing
- DEX
- dexamethasone
- NC
- non-classic
- GC
- glucocorticoid
- B
- blood
- P
- plasma
- S
- serum
- HDL
- high density lipoprotein
- LDL
- low density lipoprotein
- WISC
- Wechsler Intelligence Scale for Children
- WAIS
- Wechsler Adult Intelligence Scale
- PBMC
- peripheral blood mononuclear cells
- MACS
- magnetic activated cell sorting
- 450K array
- Illumina Infinium Human Methylation450 BeadChip Array
- SNP
- single nucleotide polymorphism
- FDR
- false discovery rate
- TSS
- transcriptional start site.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos